| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 390 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 390 |
| 2 | TACROLIMUS | 356 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 343 |
| 4 | TACROLIMUS OINTMENT 0.1% | 343 |
| 5 | METHOTREXATE SODIUM | 304 |
| 6 | FLUDARABINE PHOSPHATE | 295 |
| 7 | METHOTREXATE | 277 |
| 8 | CYCLOSPORINE | 265 |
| 9 | CYCLOPHOSPHAMIDE | 221 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 43 | 0.0156 |
| 1 | THIOTEPA | 107 | 0.0110 |
| 2 | PALIFERMIN | 4 | 0.0103 |
| 3 | BUSULFAN | 147 | 0.0092 |
| 4 | FLUDARABINE PHOSPHATE | 295 | 0.0074 |
| 5 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 7 | 0.0068 |
| 6 | BELUMOSUDIL | 21 | 0.0062 |
| 7 | SIROLIMUS | 77 | 0.0056 |
| 8 | INTERLEUKIN-10 | 2 | 0.0056 |
| 9 | MELPHALAN HYDROCHLORIDE | 95 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 343 |
| 1 | Corticosteroid [EPC] | 327 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 277 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 265 |
| 4 | Kinase Inhibitor [EPC] | 189 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 107 |
| 6 | Janus Kinase Inhibitor [EPC] | 103 |
| 7 | mTOR Inhibitor Immunosuppressant [EPC] | 86 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 71 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 68 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 4 | 0.0103 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 71 | 0.0037 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 265 | 0.0020 |
| 3 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 4 | Anthracycline Topoisomerase Inhibitor [EPC] | 4 | 0.0016 |
| 5 | Alkylating Drug [EPC] | 343 | 0.0014 |
| 6 | CD22-directed Immunoconjugate [EPC] | 4 | 0.0013 |
| 7 | Echinocandin Antifungal [EPC] | 9 | 0.0011 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 23 | 0.0011 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 22 | 0.0010 |